Medications for analgesia and sedation in the intensive care unit: An overview

Critical Care

Volumn 12, Issue SUPPL. 3, 2008, Pages

  Gommers, Diederik ^a   Bakker, Jan ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ANALGESIC AGENT; ANESTHETIC AGENT; BENZODIAZEPINE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CATECHOLAMINE; CLONIDINE; CYTOCHROME P450; DEXMEDETOMIDINE; DRUG METABOLIZING ENZYME; ERYTHROMYCIN; FENTANYL; GLUCOCORTICOID; HYPNOTIC AGENT; INHALATION ANESTHETIC AGENT; ISOFLURANE; ITRACONAZOLE; LOCAL ANESTHETIC AGENT; LORAZEPAM; MIDAZOLAM; MORPHINE; OPIATE; PROPOFOL; PROPYLENE GLYCOL; REMIFENTANIL; SEDATIVE AGENT; HYPNOTIC SEDATIVE AGENT; NARCOTIC AGENT;

ANALGESIA; ANTICONVULSANT ACTIVITY; ARTIFICIAL VENTILATION; BRADYCARDIA; CLINICAL TRIAL; CONTINUOUS INFUSION; CRITICALLY ILL PATIENT; DELIRIUM; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG DEPENDENCE; DRUG EFFICACY; DRUG ELIMINATION; DRUG INDICATION; DRUG INDUCED DISEASE; DRUG MEGADOSE; DRUG METABOLISM; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG WITHDRAWAL; EPIDURAL ANESTHESIA; EXTUBATION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPOTENSION; INJECTION SITE PAIN; INTENSIVE CARE; LENGTH OF STAY; LONG TERM CARE; PAIN; PANCREATITIS; PATIENT CONTROLLED ANALGESIA; POSTOPERATIVE ANALGESIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPOFOL INFUSION SYNDROME; RESPIRATION DEPRESSION; REVIEW; SEDATION; SHORT COURSE THERAPY; TRANQUILIZING ACTIVITY; WITHDRAWAL SYNDROME; CONSCIOUS SEDATION; CRITICAL ILLNESS; INTENSIVE CARE UNIT; METHODOLOGY; PAIN ASSESSMENT;

ANALGESIA; ANALGESICS; CONSCIOUS SEDATION; CRITICAL ILLNESS; HUMANS; HYPNOTICS AND SEDATIVES; INTENSIVE CARE UNITS; NARCOTICS; PAIN MEASUREMENT; RESPIRATION, ARTIFICIAL;

EID: 45949086910     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc6820     Document Type: Review

References (36)

1. Kress JP Pohlman AS O'Connor MF Hall JB Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation N Engl J Med 2000, 342:1471-1477. 10.1056/NEJM200005183422002 10816184
2. Karabinis A Mandragos K Stergiopoulos S Komnos A Soukup J Speelberg B Kirkham AJ Safety and efficacy of analgesia-based sedation with remifentanil versus standard hypnotic-based regimens in intensive care unit patients with brain injuries: A randomised, controlled trial Crit Care 2004, 8:R268-R280. 522854 15312228 10.1186/cc2896
3. Park G Lane M Rogers S Bassett P A comparison of hypnotic and analgesic based sedation in a general intensive care unit Br J Anaesth 2007, 98:76-82. 10.1093/bja/ael320 17158127
4. Guay J The benefits of adding epidural analgesia to general anesthesia: a metaanalysis J Anesth 2006, 20:335-340. 10.1007/s00540-006-0423-8 17072704
5. Liu SS Block BM Wu CL Effects of perioperative central neuraxial analgesia on outcome after coronary artery bypass surgery: A meta-analysis Anesthesiology 2004, 101:153-161. 10.1097/ 00000542-200407000-00024 15220785
6. Bulger EM Edwards T Klotz P Jurkovich GJ Epidural analgesia improves outcome after multiple rib fractures Surgery 2004, 136:426-430. 10.1016/ j.surg.2004.05.019 15300210
7. Bernhardt A Kortgen A Niesel HCh Goertz A Using epidural anestheia in patients with acute pancreatitis: Prospective study of 121 patients Anaesthesiol Reanim 2002, 27:16-22. 11908096
8. Low JHS Survey of epidural analgesia management in general intensive care units in England Acta Anaesthesiol Scand 2002, 46:799-805. 10.1034/ j.1399-6576.2002.460708.x 12139534
9. Soliman HM Melot C Vincent JL Sedative and analgesic practice in the intensive care unit: The results of a European survey Br J Anaesth 2001, 87:186-192. 10.1093/bja/87.2.186 11493487
10. Pasternak GW Bodnar RJ Clark JA Inturrisi CE Morphine-6-glucuronide, a potent mu agonist Life Sci 1987, 41:2845-2849. 10.1016/ 0024-3205(87)90431-0 2826951
11. Frances B Gout R Campistron G Panconi E Cros J Morphine-6-glucuronide is more mu-selective and potent in analgesic tests than morphine Prog Clin Biol Res 1990, 328:477-480. 2154808
12. Jacobi J Fraser GL Coursin DB Riker RR Fontaine D Wittbrodt ET Chalfin DB Masica MF Bjerke HS Coplin WM Crippen DW Fuchs BD Kelleher RM Marik PE Nasraway SA Jr Murray MJ Peruzzi WT Lumb PD Task Force of the American College of Critical Care Medicine (ACCM) of the Society of Critical Care Medicine (SCCM), American Society of Health-System Pharmacists (ASHP), American College of Chest Physicians Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult Crit Care Med 2002, 30:119-141. 10.1097/ 00003246-200201000-00020 11902253
13. Beers R Camporesi E Remifentanil update: Clinical science and utility CNS Drugs 2004, 18: 1085-1104. 10.2165/00023210-200418150-00004 15581380
14. Muellejans B Lopez A Cross MH Bonome C Morrison L Kirkham AJ Remifentanil versus fentanyl for analgesia based sedation to provide patient comfort in the intensive care unit: A randomized, double-blind controlled trial Crit Care 2004, 8:R1-R11. 420059 14975049 10.1186/cc2398
15. Dahaba AA Grabner T Rehak PH List WF Metzler H Remifentanil versus morphine analgesia and sedation for mechanically ventilated critically ill patients: A randomized double blind study Anesthesiology 2004, 101:640-646. 10.1097/00000542-200409000-00012 15329588
16. Breen D Karabinis A Malbrain M Morais R Albrecht S Jarnvig I-L Parkinson P Kirkham AJT Decreased duration of mechanical ventilation when comparing analgesia-based sedation using remifentanil with standard hypnotic-based sedation for up to 10 days in intensive care unit patients: A randomised trial Crit Care 2005, 9:R200. 1175879 15987391 10.1186/cc3495
17. Bakker J Mulder P Remifentanil shortens duration of mechanical ventilation and ICU stay Intensive Care Med 2006, 32(Suppl):S85.
18. Pitsiu M Wilmer A Bodenham A Breen D Bach V Bonde J Kessler P Albrecht S Fisher G Kirkham A Pharmacokinetics of remifentanil and its major metabolite, remifentanil acid, in ICU patients with renal impairment Br J Anaesth 2004, 92:493-503. 10.1093/bja/aeh086 14766712
19. Breen D Wilmer A Bodenham A Bach V Bonde J Kessler P Albrecht S Shaikh S Offset of pharmacodynamic effects and safety of remifentanil in intensive care unit patients with various degrees of renal impairment Crit Care 2004, 8:R21-R30. 420060 14975051 10.1186/cc2399
20. Amrein R Hetzel W Hartmann D Lorscheid T Clinical pharmacology of flumazenil Eur J Anaesthesiol Suppl 1988, 2:65-80. 2842143
21. Wilson KC Reardon C Theodore AC Farber HW Propylene glycol toxicity: A severe iatrogenic illness in ICU patients receiving iv benzodiazepines Chest 2005, 128:1674-1681. 10.1378/chest.128.3.1674 16162774
22. Pandharipande P Shintani A Peterson J Pun BT Wilkinson GR Dittus RS Bernard GR Ely EW Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients Anesthesiology 2006, 104:21-26. 10.1097/00000542-200601000-00005 16394685
23. Barr J Zomorodi K Bertaccini EJ Shafer SL Geller E A double-blind, randomized comparison of i.v. lorazepam versus midazolam for sedation of ICU patients via a pharmacologic model Anesthesiology 2001, 95:286-298. 10.1097/00000542-200108000-00007 11506097
24. Wappler F The propofol infusion syndrome [in German] Deutsches Arzteblatt 2006, 11:A705-A710.
25. Barr J Egan TD Sandoval NF Zomorodi K Cohane C Gambus PL Shafer SL Propofol dosing regimens for ICU sedation based upon an integrated pharmacokinetic-pharmacodynamic model Anesthesiology 2001, 95:324-333. 10.1097/00000542-200108000-00011 11506101
26. Ostermann ME Keenan SP Seiferling RA Sibbald WJ Sedation in the intensive care unit: A systematic review JAMA 2000, 283:1451-1459. 10.1001/jama.283.11.1451 10732935
27. Hall RI Sandham D Cardinal P Tweeddale M Moher D Wang X Anis AH Study Investigators Propofol vs midazolam for ICU sedation: A Canadian multicenter randomized trial Chest 2001, 119:1151-1159. 10.1378/ chest.119.4.1151 11296183
28. Szumita PM Baroletti SA Anger KE Wechsler ME Sedation and analgesia in the intensive care unit: Evaluating the role of dexmedetomidine Am J Health Syst Pharm 2007, 64:37-44. 10.2146/ajhp050508 17189578
29. Martin E Ramsay G Mantz J Sum-Ping STJ The role of the α2-adrenoceptor agonist dexmedetomidine in postsurgical sedation in the intensive care J Intensive Care Med 2003, 18:29-41. 10.1177/ 0885066602239122 15189665
30. Venn RM Newman PJ Grounds RM A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the intensive care unit Intensive Care Med 2003, 29:201-207. 12594584
31. Kong KL Willarts SM Prys-Roberts C Isoflurane compared with midazolam for sedation in the intensive care unit BMJ 1989, 298:1277-1280. 1836531 2500195
32. Spencer EM Willatts SM Isoflurane for prolonged sedation in the intensive care unit: Efficacy and safety Intensive Care Med 1992, 18:415-421. 10.1007/BF01694344 1469180
33. Millane TA Bennet ED Grounds RM Isoflurane and propofol for long-term sedation in the intensive care unit: A crossover study Anaesthesia 1992, 47:768-774. 10.1111/j.1365-2044.1992.tb03254.x 1415973
34. Berton J Sargentini C Nguygen JL Belii A Beydon L AnaConDa reflection filter: Bench and patient evaluation of safety and volatile anesthetic conservation Anesth Analg 2007, 104:130-134. 10.1213/ 01.ane.0000248221.44383.43 17179257
35. Sackey PV Martling C-R Granath F Radell PJ Prolonged isoflurane sedation of intensive care unit patients with the anesthetic conserving device Crit Care Med 2004, 32:2241-2246. 15640636
36. Carpenter RL Eger EI 2nd Johnson BH Unackat JP Sheiner LB The extent of metabolism of inhaled anesthetics in humans Anesthesiology 1986, 65:201-205. 10.1097/00000542-198609001-00200 3740510